Intravascular blood filter

Information

  • Patent Grant
  • 12048618
  • Patent Number
    12,048,618
  • Date Filed
    Tuesday, May 24, 2022
    2 years ago
  • Date Issued
    Tuesday, July 30, 2024
    4 months ago
Abstract
Disclosed is a novel filter and delivery means. The device described within will not interfere with standard practice and tools used during standard surgical procedures and tools such as cannulas, clamps or dissection instruments including valve replacement sizing gages or other surgical procedures where the patient must be put on a heart-lung machine cross-clamping the aorta.
Description
INCORPORATION BY REFERENCE

All publications and patent applications mentioned in this specification are herein incorporated by reference to the same extent as if each individual publication or patent application was specifically and individually indicated to be incorporated by reference.


BACKGROUND OF THE INVENTION

This invention relates generally to medical devices used during vascular intervention, and more particularly, concerns medical devices that are useful in treating aortic valve replacement, thromboembolic disorders and for removal of foreign bodies in the vascular system.


Thromboembolic disorders, such as stroke, pulmonary embolism, peripheral thrombosis, atherosclerosis, and the like, affect many people. These disorders are a major cause of morbidity and mortality in the United States and throughout the world. Thromboembolic events are characterized by an occlusion of a blood vessel. The occlusion can be caused by a clot which is viscoelastic (jelly-like) and is comprised of platelets, fibrinogen, and other clotting proteins.


Percutaneous aortic valve replacement has been in development for some time now and stroke rates related to this procedure are between four and twenty percent. During catheter delivery and implantation plaque may be dislodged from the vasculature. The invention contained within will block the emboli from traveling through the carotid circulation and onto the brain. When an artery is occluded by a clot, tissue ischemia (lack of oxygen and nutrients) develops. The ischemia will progress to tissue infarction (cell death) if the occlusion persists. Infarction does not develop or is greatly limited if the flow of blood is reestablished rapidly. Failure to reestablish blood-flow can lead to the loss of limb, angina pectoris, myocardial infarction, stroke, or even death.


Occlusion of the venous circulation by thrombi leads to blood stasis which can cause numerous problems. The majority of pulmonary embolisms are caused by emboli that originate in the peripheral venous system. Reestablishing blood flow and removal of the thrombus is highly desirable.


There are many existing techniques employed to reestablish blood flow in an occluded vessel. One common surgical technique, an embolectomy, involves incising a blood vessel and introducing a balloon-tipped device (such as a Fogarty catheter) to the location of the occlusion. The balloon is then inflated at a point beyond the clot and used to translate the obstructing material back to the point of incision. The obstructing material is then removed by the surgeon. While such surgical techniques have been useful, exposing a patient to surgery may be traumatic and is best avoided when possible. Additionally, the use of a Fogarty catheter may be problematic due to the possible risk of damaging the interior lining of the vessel as the catheter is being withdrawn.


A common percutaneous technique is referred to as balloon angioplasty where a balloon-tipped catheter is introduced into a blood vessel, typically through an introducing catheter. The balloon-tipped catheter is then advanced to the point of the occlusion and inflated in order to dilate the stenosis. Balloon angioplasty is appropriate for treating vessel stenosis but is generally not effective for treating acute thromboembolisms.


Another percutaneous technique is to place a microcatheter near the clot and infuse Streptokinase, Urokinase, or other thrombolytic agents to dissolve the clot. Unfortunately, thrombolysis typically takes hours to days to be successful. Additionally, thrombolytic agents can cause hemorrhage and in many patients the agents cannot be used at all.


Another problematic area is the removal of foreign bodies. Foreign bodies introduced into the circulation can be fragments of catheters, pace-maker electrodes, guide wires, and erroneously placed embolic material such as thrombogenic coils. There exist retrieval devices for the removal of foreign bodies, certain of such devices form a loop that can ensnare the foreign material by decreasing the size of the diameter of the loop around the foreign body. The use of such removal devices can be difficult and sometimes unsuccessful.


Moreover, systems heretofore disclosed in the art are generally limited by size compatibility and the increase in vessel size as the emboli is drawn out from the distal vascular occlusion location to a more proximal location near the heart. If the embolectomy device is too large for the vessel it will not deploy correctly to capture the clot or foreign body, and if too small in diameter it cannot capture clots or foreign bodies across the entire cross section of the blood vessel. Additionally, if the embolectomy device is too small in retaining volume then as the device is retracted the excess material being removed can spill out and be carried by flow back to occlude another distal vessel.


Various thrombectomy and foreign matter removal devices have been disclosed in the art. However, such devices have been found to have structures which are either highly complex or lacking in sufficient retaining structure. Disadvantages associated with the devices having highly complex structure include difficulty in manufacturability as well as difficulty in use in conjunction with microcatheters. Recent developments in the removal device art features umbrella filter devices having self folding capabilities. Typically, these filters fold into a pleated condition, wherein the pleats extend radially and can obstruct retraction of the device into the micro catheter sheathing.


What has been needed and heretofore unavailable is an extraction device that can be easily and controllably deployed into and retracted from the circulatory system for the effective removal of clots and foreign bodies. There is also a need for a system that can be used as a temporary arterial or venous filter to capture and remove thromboemboli generated during endovascular procedures. Moreover, due to difficult-to-access anatomy such as the cerebral vasculature and the neurovasculature, the invention should possess a small collapsed profile and preferably be expandable to allow the device to be delivered through the lumen of commercially available catheters. The present invention satisfies these needs.


SUMMARY OF THE INVENTION

Most filter devices are delivered from the groin and are placed distal to the flow of the lesion or site in question. Single basket-type filters or Nitinol loop filters are the most common used today in carotid stent procedures of vein graft stenting. As the guidewire is delivered past the lesion the filter is delivered over the guidewire protecting the distal vasculature. The invention here may be delivered from the groin in a conventional manner to vessels such as the carotid arteries or via radial (arm vasculature) approach. Protecting the carotid arteries and cerebral vasculature system is the main goal while leaving the aortic arch free from catheters and wire as much as possible during the delivery of other devices such as aortic balloons and prosthetic valves or other associated devices.


One method of filtering the carotid arteries leaving the aorta free from obstruction is to deliver a filter to each of the carotid arteries from the groin leaving them in the carotid vasculature and retrieving them via snare post procedure. A delivery catheter would be inserted through an introducer in the groin (femoral artery) and delivered to the common carotid arteries and detached. The delivery catheter would be removed and a second filter would be delivered in a similar manner to the other carotid artery. With two detached filters now in place the procedure treating the aortic or mitral valve can now be completed with embolic protection for the cerebral vascular system. Once the procedure to the valve is completed, the filters can be snared and retrieved back out the femoral artery as they were delivered. Any embolic particles will be captured in the filter device and removed safely from the body.


Another method for filtering the carotid arteries would be to deliver a filter from the femoral artery and utilize a single catheter to house the two attachment means to the filters. These attachments may be a wire similar to a guidewire or a hypo-tube to connect the filter element to an external portion of the body. Keeping these wires or connection means organized and contained within a single or dual lumen catheter will help organize and limit potential entanglement with other catheters being delivered to the target site such as the aortic valve or other cardiac elements including but not limited to the mitral valve and coronary arteries. The distal portion of the catheter may have a single exit portion or a staggered exit to allow an exit at different points along the catheter. One exit port may be at the distal most end of the catheter and the other may be a centimeter proximal from this to allow the attachment wire to exit near the left common carotid artery. Furthermore, there could be an extension to the distal most portion of the catheter allowing side ports for both wires to exit. This would allow for additional catheter stabilization within the aorta.


Another embodiment would deliver filters to the carotid from the radial artery and allow for a clear aortic arch from catheters and other delivery means from a more conventional femoral delivery means. From this access site a plurality of filters could be delivered through a common access sheath or the filters could be delivered from a dual lumen catheter with each lumen housing a single filter.


Another delivery means would utilize a single catheter with filters mounted in a coaxial manner where the distal filter would be delivered first and could be mounted to a wire where the second would be mounted to a hypo-tube where the first filters wire would run through the second allowing for relative motion between the two filters. The first filter would be delivered to the left common carotid from the radial artery and the second would be delivered to the right common carotid artery or the brachiocephalic trunk in a coaxial manner. These filters would be opposed in direction as the distal filter would be filtering blood flowing from the base of the aorta to the head and toward the distal end of the guidewire. The proximal filter would be filtering blood from the base of the aorta to the head and toward the proximal end of the guidewire. Placing the two filters together there would be a conical shape configuration where the large diameter portions of the cones would meet. These two filters would be delivered in a collapsed configuration and expanded when expelled from the delivery catheter. Retrieval would be a retraction of the filter back into a recovery catheter that would be a larger inner diameter than the delivery catheter to allow room for particulate. Being opposed in capture direction the right carotid would be the first filter that would be recovered by an expanded sheath where the embolic material would not be disturbed and further withdrawn to a smaller sheath for removal from the body. The expanded sheath could be constructed from braided Nitinol wire pre-shaped so when exposed the braid would expand to receive the filter without squeezing out any trapped emboli. The second or left carotid filter would be recovered in a conventional manner where the larger diameter would be pulled into a sheath to trap and remove the emboli within the tailor distal portion of the filter.


Another means to deliver the filters via radial artery approach would be to utilize a dual lumen catheter where each lumen would house a single filter. The first lumen would deliver a filter to the left carotid artery and the second lumen would deliver a filter to the right carotid artery. The lumens could be staggered in length to reach each ostium in which case the first or left filter lumen would be longer in length to allow for placement distal from the second filter placement in the right carotid. Additionally, the second lumen may be pre-shaped with a curve to allow easy access to the right carotid artery. This pre-shaped curve may be retained in a straighter manner to allow for delivery and released to express the delivery shape when at the bifurcation of the subclavian and the carotid artery. Furthermore, there may be an active shaping where the curve is directed external to the body by a handle mechanism such as a pull-wire where tension would generate a compressive force to the catheter column preferentially bending the lumen. Recovery could utilize the same dual lumen concept or utilize a second recovery sheath independently from one another.


Another application for this device and method would be for surgical operations where the patient may be put on heart-lung bypass. During cross clamping of the aorta catheters or wires in the aorta may interfere with the procedure and allow leakage of blood around the cannulas used. If any of the above described devices or techniques are used before the patient's chest is opened this filtration of the carotid vessels would protect from emboli thus reducing the stroke risk during and after the procedure. Additional anti thrombotic coatings to the filter could allow for an extended implantation time allowing filtration time to be extended post procedure. An example of this coating would be Heparin. Placement of these catheters and filters could be under fluoroscopy or ultrasound guidance to direct proper filter placement. Radiopaque markers may add necessary visibility to the catheter, filter and or wires.


Another surgical delivery means would be an insertion to the carotid artery via the neck. The filter could face either antigrade or retrograde depending upon the placement insertion point or access site. This would allow for complete filtration without any aortic interference as the entire devices would be within the carotid circulation. With this delivery technique the puncture site would be very small and recovery could be through the entry site or through the groin as the filter could be inserted distal to meet a recovery sheath in the aorta. With this groin recovery any emboli within the proximal carotid would be captured before later dislodgement.


Intravascular filters have been used in many configurations ranging from a windsock style as commercialized as the FilterWire from Boston Scientific or the ACCUNET from Abbott Vascular or the Spider from eV3. These filters utilize a memory metal such as Nitinol is used to oppose the vascular wall tightly sealing any emboli from passage while a filter material such as a porous fabric material retains and emboli from passing distally from the device. Another example is a laser cut memory metal where the basket is the frame and the filter is used to trap emboli when expanded. Another example is constructed from a braided wire such as Medtronic's Interceptor PLUS where once exposed the braid expands to create a funnel or cone shape to trap emboli and the proximal or larger end is pre-shaped to accept blood flow with larger openings heat-set into the memory metal such as Nitinol. These filters range in diameter from about 2-15 mm in diameter and are approximately 20-30 mm in length. They are generally attached to a guidewire and sheathed for delivery and resheathed for recovery. The catheter profile measures about 1 to 2 mm in diameter and has a length of about 90 to 200 cm. Catheter construction is normally a polypropylene or polyethylene material but nylons and blends can be used as well. All devices are considered single use and are commonly placed for carotid stenting or savenous vein grafts stenting.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 illustrates the vascular anatomy of the aorta and surrounding great vessels.



FIG. 2 illustrates the common technique in carotid filter 8 insertion for carotid stenting 10 as delivered via femoral artery over a guidewire 9.



FIG. 3 illustrates the aortic vasculature where sheaths could be placed by the interventional cardiologist. The right femoral 11 being the most common access as the cardiologist works from the right side of the patient which is presented to the physician while on the table. The right radial artery 12 has been used but due to the small diameter of the vessel is not a common insertion point for the cardiologist.



FIG. 4 illustrates a brachial entry with common introducer 13 and guidewire 8 techniques.



FIG. 5 illustrates the guide catheter 14 being inserted to the introducer 13 over the guidewire 8 in a brachial artery entry where the guide catheter 14 has a preshaped distal section to access the left common carotid 3.



FIG. 6 illustrates a closer view of the guide catheter 14 and guidewire 8 accessing the left carotid artery where the first filter would be placed.



FIG. 7 illustrates the deployment of the first filter 9 through the guide catheter 14 over a guidewire 8 where the filter 9 is fully opposed to the left carotid artery.



FIG. 8 illustrates both filters 9 deployed and protecting the carotid arteries utilizing a common guidewire 8 and common guide catheter 14.



FIG. 9 illustrates a dual lumen catheter 29 where each filter 9 has a single guidewire 8. Both filters 9 are in a conventional orientation where the flow is in the distal direction or toward the distal tip of the guidewire 8. Independent recovery of the filters 9 could occur or a common recovery sheath may be used to load both into one sheath.



FIG. 10 illustrates both filters 9 being delivered via subclavian where the left filter is delivered via left subclavian artery with an entry point in the radial artery. Each delivery would include a guidewire 8 and a guide catheter 14 where a pre-shaped curve would allow access into the respective carotid artery.



FIG. 11 illustrates a single organization catheter 15 to retain two filter 9 guidewires 8 controlling the potential for entanglement with each wire or other catheters introduced to the body. These catheters would include pigtail catheters used for contrast injections, balloon catheters for dilation or other catheters for delivery of therapeutic agents or implantable devices such as stents or prosthetic heart valves where the catheters are generally larger (18-26 French) in diameter. The catheter would have two distal exit ports to allow each filter to exit at the respective ostia. A distal section would extend beyond the brachiocephalic trunk allowing for a smooth shape to the catheter and ensure it is close to the outer radius of the arch.



FIG. 12 illustrates a dual lumen catheter 16 with an active curving mechanism to steer each lumen to the respected carotid artery. The deflection will allow for active steering of each distal section to account for any differences in anatomy from patient to patient. Similar to electrophysiology catheters a deflection wire 18 could be tensioned to provide a bias or curve to tip. The delivery of each filter would be in a conventional orientation where the blood flow would be in the distal direction and toward the tip of the guidewire. External to the body would be a handle mechanism 17 providing an actuation force to the distal portion of the catheter. This actuation could be a rotational knob 19 translating a rotation movement to a screw mechanism providing a tension to a wire connected to the catheter tip. Other methods could include an electrical signal to drive a motion or hydraulic actuation to translate a force.



FIG. 13 illustrates a filter 9 delivered over the guidewire 8 from the carotid artery in a retrograde approach just short of the aortic arch. Once the procedure is completed the filter can be snared with a conventional snare 20 to remove it from the body. This will allow for a very small (0.03 inch) entry port in the neck to introduce the device and a larger recovery sheath 21 in the groin where other devices are introduced.



FIG. 14 illustrates a set of filters in the carotid arteries delivered and ready for additional procedures to occur under filtered protection. During a percutaneous heart valve delivery there may be multiple catheters in the aortic arch consuming much of the available area. Shown here is a pigtail catheter 22 and a delivery catheter 24 for a percutaneous heart valve 23 all within the aortic arch. The filters 9 are clear of the aortic space and will not interfere with delivery or withdrawal of these catheters.



FIG. 15 illustrates another delivery pathway for the placement in the carotid or brachiocephalic trunk. Delivery includes a guidewire 8 introduced via carotid artery or subclavian artery just short of the aortic arch leaving the arch free from interference while delivering other catheters to the heart. These filters 9 can be retrieved either through the groin or recovered back through the entry point in the carotid or subclavian artery.



FIG. 16 illustrates a conventional entry to the carotid artery where the sheath is placed in a retrograde manner. A sheath 13 is placed into the carotid artery where access may be gained to the vasculature either anti grade or retrograde depending upon the desired placement of the device.



FIG. 17 illustrates an example of a common filter design where the guidewire 8 passes through the central portion of the filter 27. A memory material such as Nitinol is used to expand the filter material to the vessel wall.



FIGS. 18A-B illustrate other examples of filters where a loop style 25 has the guidewire passing along the side of the device and functions like a wind-sox when deployed in the vessel. The other example is a framed filter where when expanded the filter material is opposed to the vessel wall and the guidewire 8 passes through the central portion of the device.





DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENT

Before standard intervention would occur by a cardiologist a filter would be placed into the carotid arteries to protect the circulation to the brain where emboli could induce a stroke and leave the patient debilitated. Placement of these filters to the patient's carotid circulation would be most convenient if it occurred without obstruction of the aorta where other catheters would be passed and preferably on the patient's right side as it is common practice for the doctor to steer the catheters from this side of the table. Standard practice is to gain access in the right femoral artery where a sheath would be placed to introduce catheters, guidewires and other device delivery means. This would leave the left femoral artery open but often it too is used for other diagnostic catheters and it is less convenient to work across the patient's body. Other access sites would include carotid entry but the neck area is often again inconvenient to operate from and generally too far from the other wires and catheters. The final entry point would be an arm entry where a sheath would be placed into the brachial or radial artery for access to the subclavian artery and more distally the aorta and the carotid arteries. This approach would allow the doctor to access the patient's right arm placing a sheath into the radial artery and delivering catheters, guidewires and sheaths to the carotid arteries. After a 5 French sheath placement a guide catheter would be placed into the radial artery and advanced to the brachiocephalic trunk where the right carotid artery meets the subclavian. From here a curve in the guide catheter would allow a 180 turn to occur accessing from the brachiocephalic trunk into the aortic arch and back up the left carotid artery which is commonly found one centimeter down the aortic arch. Once the guide catheter is place a filter may be advanced into the left carotid artery and deployed leaving this vessel protected from emboli. The guide catheter could be moved proximally to leave this vasculature and back into the brachiocephalic trunk artery where a coaxial filter could now be placed protecting this carotid artery. The connection between the two filters is a common axial link where the distal or left carotid filter would be attached to a 0.014 inch guidewire as normally constructed and the more proximal filter would utilize a tubular member such as a polymer or Nitinol hypo tube. The distal filter may need to be gently engaged to the vessel wall to allow the connection guidewire to be tensioned removing any slack or loop within the aortic arch. This may be possible with engagement barbs restricting proximal motion of the device in the vessel when deployed. Other means may be a stronger force in the memory metal loop to keep the device opposed to the wall. Now the circulation to the brain is protected and the aortic arch is clear from obstruction the normal procedure can occur. Examples of these procedures include but are not limited to: [0042] Coronary stenting [0043] Aortic valve replacement via catheterization [0044] Aortic or mitral valve replacement via transapical [0045] Aortic balloon valvuloplasty [0046] Mitral valvuloplasty [0047] Mitral valve replacement via catheterization [0048] Diagnostic catheterization [0049] Surgical valve replacement (aortic or mitral) [0050] Surgical valve repair (aortic or mitral) [0051] Annuloplasty ring placement [0052] Atrial fibrillation catheterization [0053] PFO closure (surgical or catheter based) [0054] Left atrial appendage closure (catheter or surgical)


Once the procedure has been completed the filters may be removed immediately or left in place if an antitrombotic coating is added or the patient remains on blood thinning agents to limit clot from forming on the filters. It may be advantageous to leave the filters in for a period of twenty four hours as the patient begins to recover. When removal is necessary the goal is to not dislodge any trapped emboli within the filter. Conventionally this is accomplished by pulling the filter into a larger recovery sheath to first close the open end of the filter and draw the remaining portion safely back into the recovery catheter. With the filters being opposed in direction it may be advantageous to move the distal filter into the proximal filter and recover them both together in a nested orientation.

Claims
  • 1. A method of preventing foreign material from traveling into carotid circulation, the method comprising: advancing a filter system through a right subclavian artery and into a brachiocephalic artery, the filter system including a guide catheter, a first filter, and a second filter;advancing the first filter into a left common carotid artery and expanding the first filter; andadvancing the second filter into a right common carotid artery and expanding the second filter.
  • 2. The method of claim 1, wherein the guide catheter includes a first lumen configured to receive the first filter and a second lumen configured to receive the second filter, wherein advancing the first filter includes advancing the first filter through the first lumen and advancing the second filter includes advancing the second filter through the second lumen.
  • 3. The method of claim 2, wherein the guide catheter includes an active curving mechanism, wherein advancing the first filter includes steering the first filter into the left common carotid artery and advancing the second filter includes steering the second filter into the right common carotid artery.
  • 4. The method of claim 3, wherein the active curving mechanism includes at least one deflection wire, wherein advancing the first filter includes moving the deflection wire to move the first filter from the brachiocephalic artery into the left common carotid artery, wherein advancing the second filter includes moving the deflection wire to move the second filter from the brachiocephalic artery into the right common carotid artery.
  • 5. The method of claim 4, wherein advancing the second filter includes bending the second lumen into the right common carotid artery.
  • 6. The method of claim 4, wherein the guide catheter includes a proximal handle with a rotational knob coupled to the deflection wire, wherein advancing the first and second filters includes rotating the rotational knob to move the deflection wire.
  • 7. The method of claim 3, wherein advancing the second filter includes bending the second lumen from the brachiocephalic artery into the right common carotid artery.
  • 8. A method of preventing foreign material from traveling into carotid circulation, the method comprising: advancing a filter system through a right subclavian artery and into a brachiocephalic artery, the filter system including a guide catheter having a first lumen and a second lumen, a first filter, a second filter, and at least one deflection wire configured to steer the first filter and the second filter;advancing and steering the first lumen and the first filter from the brachiocephalic artery into a left common carotid artery and expanding the first filter; andadvancing and steering the second lumen and the second filter into a right common carotid artery and expanding the second filter.
  • 9. The method of claim 8, wherein the first filter is mounted on a first guidewire and wherein advancing and steering the first filter includes steering the first guidewire into the left common carotid artery.
  • 10. The method of claim 9, wherein the second filter is mounted on a second guidewire and wherein advancing and steering the second filter includes steering the second guidewire into the right common carotid artery.
  • 11. The method of claim 8, wherein the guide catheter includes a proximal handle with a rotational knob coupled to the at least one deflection wire, wherein advancing the first and second filters includes rotating the rotational knob to move the at least one deflection wire.
CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a continuation of U.S. application Ser. No. 16/934,962, filed Jul. 21, 2020, which is a continuation of U.S. Ser. No. 15/838,949, filed Dec. 12, 2017, which is a continuation of U.S. application Ser. No. 13/738,847, filed Jan. 10, 2013, which is a continuation of U.S. application Ser. No. 12/689,997, filed Jan. 19, 2010, now U.S. Pat. No. 8,372,108, which claims priority benefit under 35 U. S. C. .sctn. 119(e) to U.S. Provisional Application No. 61/145,149, filed Jan. 16, 2009, entitled “Intravascular Blood Filter,” all of which applications are hereby incorporated by reference in their entirety.

US Referenced Citations (292)
Number Name Date Kind
3472230 Fogarty Oct 1969 A
4619246 Molgaard-Nielsen et al. Oct 1986 A
4630609 Chin Dec 1986 A
4650466 Luther Mar 1987 A
4706671 Weinrib Nov 1987 A
4723549 Wholey et al. Feb 1988 A
4873978 Ginsburg Oct 1989 A
5108419 Reger Apr 1992 A
5192286 Phan et al. Mar 1993 A
5200248 Thompson et al. Apr 1993 A
5329923 Lundquist Jul 1994 A
5348545 Shani et al. Sep 1994 A
5381782 DeLaRama et al. Jan 1995 A
5395327 Lundquist et al. Mar 1995 A
5613980 Chauhan Mar 1997 A
5624430 Eton et al. Apr 1997 A
5662671 Barbut et al. Sep 1997 A
5680873 Berg et al. Oct 1997 A
5707389 Louw et al. Jan 1998 A
5766151 Valley et al. Jun 1998 A
5779716 Cano et al. Jul 1998 A
5814064 Daniel et al. Sep 1998 A
5827324 Cassell Oct 1998 A
5833650 Imran Nov 1998 A
5848964 Samuels Dec 1998 A
5897529 Ponzi Apr 1999 A
5897819 Miyata et al. Apr 1999 A
5910154 Tsugita et al. Jun 1999 A
5910364 Miyata et al. Jun 1999 A
5911734 Tsugita et al. Jun 1999 A
5935139 Bates Aug 1999 A
5980555 Barbut et al. Nov 1999 A
5989281 Barbut et al. Nov 1999 A
5993469 McKenzie et al. Nov 1999 A
6001118 Daniel et al. Dec 1999 A
6010522 Barbut et al. Jan 2000 A
6027520 Tsugita et al. Feb 2000 A
6042598 Tsugita et al. Mar 2000 A
6045547 Ren et al. Apr 2000 A
6051014 Jang Apr 2000 A
6080140 Swaminathan et al. Jun 2000 A
6083239 Addis Jul 2000 A
6096053 Bates Aug 2000 A
6099534 Bates et al. Aug 2000 A
6120494 Jonkman Sep 2000 A
6126673 Kim et al. Oct 2000 A
6129739 Khosravi Oct 2000 A
6142987 Tsugita Nov 2000 A
6146396 Konya Nov 2000 A
6152946 Broome et al. Nov 2000 A
6171328 Addis Jan 2001 B1
6179851 Barbut et al. Jan 2001 B1
6179861 Khosravi et al. Jan 2001 B1
6203561 Ramee et al. Mar 2001 B1
6214026 Lepak et al. Apr 2001 B1
6235045 Barbut et al. May 2001 B1
6245087 Addis Jun 2001 B1
6245088 Lowery Jun 2001 B1
6245089 Daniel et al. Jun 2001 B1
6264663 Cano Jul 2001 B1
6270513 Tsugita et al. Aug 2001 B1
6277138 Levinson et al. Aug 2001 B1
6287321 Jang Sep 2001 B1
6290710 Cryer et al. Sep 2001 B1
6309399 Barbut et al. Oct 2001 B1
6325815 Kusleika et al. Dec 2001 B1
6336934 Gilson et al. Jan 2002 B1
6336116 Brooks et al. Feb 2002 B1
6361545 Macoviak et al. Mar 2002 B1
6364900 Heuser Apr 2002 B1
6371970 Khosravi Apr 2002 B1
6371971 Tsugita et al. Apr 2002 B1
6375628 Zadno-Azizi et al. Apr 2002 B1
6383174 Eder May 2002 B1
6383205 Samson May 2002 B1
6440120 Maahs Aug 2002 B1
6454799 Schreck Sep 2002 B1
6485502 Don Michael Nov 2002 B2
6499487 McKenzie et al. Dec 2002 B1
6517559 O'Connell Feb 2003 B1
6530939 Hopkins et al. Mar 2003 B1
6537297 Tsugita et al. Mar 2003 B2
6544279 Hopkins et al. Apr 2003 B1
6558356 Barbut May 2003 B2
6589263 Hopkins et al. Jul 2003 B1
6595983 Voda Jul 2003 B2
6605102 Mazzocchi Aug 2003 B1
6616679 Khosravi et al. Sep 2003 B1
6620148 Tsugita Sep 2003 B1
6620182 Khosravi et al. Sep 2003 B1
6648837 Kato et al. Nov 2003 B2
6663652 Daniel et al. Dec 2003 B2
6676682 Tsugita et al. Jan 2004 B1
6712834 Yassour et al. Mar 2004 B2
6712835 Mazzocchi Mar 2004 B2
6719717 Johnson et al. Apr 2004 B1
6726621 Suon et al. Apr 2004 B2
6726651 Robinson et al. Apr 2004 B1
6726701 Gilson Apr 2004 B2
6740061 Oslund May 2004 B1
6817999 Berube et al. Nov 2004 B2
6830579 Barbut Dec 2004 B2
6843798 Kusleika et al. Jan 2005 B2
6872216 Daniel Mar 2005 B2
6881194 Miyata et al. Apr 2005 B2
6887258 Denison et al. May 2005 B2
6905490 Parodi Jun 2005 B2
6907298 Smits et al. Jun 2005 B2
6958074 Russell Oct 2005 B2
6969396 Krolik et al. Nov 2005 B2
7011094 Rapacki et al. Mar 2006 B2
7048752 Mazzocchi May 2006 B2
7094249 Broome Aug 2006 B1
7115134 Chambers Oct 2006 B2
7160255 Saadat Jan 2007 B2
7169161 Bonnette et al. Jan 2007 B2
7169165 Belef et al. Jan 2007 B2
7182757 Miyata et al. Feb 2007 B2
7214237 Don Michael May 2007 B2
7278974 Kato et al. Oct 2007 B2
7303575 Ogle Dec 2007 B2
7306618 Demond et al. Dec 2007 B2
7313445 McVenes et al. Dec 2007 B2
7323001 Clubb et al. Jan 2008 B2
7329278 Seguin et al. Feb 2008 B2
7399308 Borillo et al. Jul 2008 B2
7410491 Hopkins Aug 2008 B2
7493154 Bonner et al. Feb 2009 B2
7559925 Goldfarb et al. Jul 2009 B2
7572272 Denison et al. Aug 2009 B2
7621904 McFerran et al. Nov 2009 B2
7722634 Panetta et al. May 2010 B2
7766961 Patel et al. Aug 2010 B2
7918859 Katoh et al. Apr 2011 B2
7922732 Mazzocchi et al. Apr 2011 B2
7976562 Bressler et al. Jul 2011 B2
7998104 Chang Aug 2011 B2
8002790 Brady et al. Aug 2011 B2
8021351 Boldenow et al. Sep 2011 B2
8052713 Khosravi et al. Nov 2011 B2
8092483 Galdonik et al. Jan 2012 B2
8372108 Lashinski Feb 2013 B2
8382788 Galdonik Feb 2013 B2
8460335 Carpenter Jun 2013 B2
8518073 Lashinski Aug 2013 B2
8753370 Lashinski Jun 2014 B2
8876796 Fifer et al. Nov 2014 B2
8974489 Lashinski Mar 2015 B2
9017364 Fifer et al. Apr 2015 B2
9055997 Fifer et al. Jun 2015 B2
9259306 Fifer et al. Feb 2016 B2
9326843 Lee et al. May 2016 B2
9345565 Fifer et al. May 2016 B2
9480548 Carpenter Nov 2016 B2
9492264 Fifer et al. Nov 2016 B2
9566144 Purcell et al. Feb 2017 B2
9636205 Lee et al. May 2017 B2
9943395 Fifer et al. Apr 2018 B2
20010041858 Ray et al. Nov 2001 A1
20020022858 Demond et al. Feb 2002 A1
20020026145 Bagaoisan et al. Feb 2002 A1
20020055767 Forde et al. May 2002 A1
20020068015 Polaschegg et al. Jun 2002 A1
20020077596 McKenzie et al. Jun 2002 A1
20020095170 Krolik et al. Jul 2002 A1
20020095172 Mazzocchi et al. Jul 2002 A1
20020123761 Barbut et al. Sep 2002 A1
20020161394 Macoviak et al. Oct 2002 A1
20020165571 Herbert et al. Nov 2002 A1
20020165573 Barbut Nov 2002 A1
20030100919 Hopkins et al. May 2003 A1
20030130684 Brady et al. Jul 2003 A1
20030144686 Martinez et al. Jul 2003 A1
20030171770 Kusleika et al. Sep 2003 A1
20030199960 Paskar Oct 2003 A1
20040002730 Denison et al. Jan 2004 A1
20040006370 Tsugita Jan 2004 A1
20040044350 Martin et al. Mar 2004 A1
20040044360 Lowe Mar 2004 A1
20040064092 Tsugita et al. Apr 2004 A1
20040093015 Ogle May 2004 A1
20040138529 Wiltshire Jul 2004 A1
20040167565 Beulke et al. Aug 2004 A1
20040193206 Gerberding Sep 2004 A1
20040215167 Belson Oct 2004 A1
20040215230 Frazier Oct 2004 A1
20040220611 Ogle Nov 2004 A1
20040225321 Krolik et al. Nov 2004 A1
20040230220 Osborne Nov 2004 A1
20040243175 Don Michael Dec 2004 A1
20040254601 Eskuri Dec 2004 A1
20040254602 Lehe et al. Dec 2004 A1
20050010285 Lambrecht et al. Jan 2005 A1
20050065397 Saadat et al. Mar 2005 A1
20050080356 Dapolito et al. Apr 2005 A1
20050085847 Galdonik et al. Apr 2005 A1
20050101987 Salahieh May 2005 A1
20050131449 Salahieh et al. Jun 2005 A1
20050137696 Salahieh Jun 2005 A1
20050177132 Lentz et al. Aug 2005 A1
20050209631 Galdonik et al. Sep 2005 A1
20050277976 Galdonik et al. Dec 2005 A1
20060015136 Besselink Jan 2006 A1
20060015138 Gertner Jan 2006 A1
20060030877 Martinez et al. Feb 2006 A1
20060041188 Dirusso et al. Feb 2006 A1
20060047301 Ogle Mar 2006 A1
20060089618 McFerran et al. Apr 2006 A1
20060089666 Linder et al. Apr 2006 A1
20060100658 Obana et al. May 2006 A1
20060100662 Daniel et al. May 2006 A1
20060129180 Tsugita et al. Jun 2006 A1
20060135961 Rosenman et al. Jun 2006 A1
20060136043 Cully et al. Jun 2006 A1
20060149350 Patel et al. Jul 2006 A1
20060161241 Barbut et al. Jul 2006 A1
20060200047 Galdonik et al. Sep 2006 A1
20060200191 Zadno-Azizi Sep 2006 A1
20060259066 Euteneuer Nov 2006 A1
20070005131 Taylor Jan 2007 A1
20070043259 Jaffe et al. Feb 2007 A1
20070060944 Boldenow et al. Mar 2007 A1
20070088244 Miller et al. Apr 2007 A1
20070088383 Pal et al. Apr 2007 A1
20070173878 Heuser Jul 2007 A1
20070191880 Cartier et al. Aug 2007 A1
20070208302 Webster et al. Sep 2007 A1
20070244504 Keegan et al. Oct 2007 A1
20080004687 Barbut Jan 2008 A1
20080033467 Miyamoto et al. Feb 2008 A1
20080058860 Demond et al. Mar 2008 A1
20080065145 Carpenter Mar 2008 A1
20080065147 Mazzocchi et al. Mar 2008 A1
20080086110 Galdonik et al. Apr 2008 A1
20080109088 Galdonik et al. May 2008 A1
20080125848 Kusleika et al. May 2008 A1
20080147013 Breton Jun 2008 A1
20080154153 Heuser Jun 2008 A1
20080172066 Galdonik et al. Jun 2008 A9
20080188884 Gilson et al. Aug 2008 A1
20080234722 Bonnette et al. Sep 2008 A1
20080262442 Carlin et al. Oct 2008 A1
20080300462 Intoccia et al. Dec 2008 A1
20090024072 Criado et al. Jan 2009 A1
20090024153 Don Michael Jan 2009 A1
20090069840 Hallisey Mar 2009 A1
20090198269 Hannes et al. Aug 2009 A1
20090203962 Miller et al. Aug 2009 A1
20090254172 Grewe et al. Oct 2009 A1
20090281619 Le Nov 2009 A1
20090287187 Legaspi et al. Nov 2009 A1
20090326575 Galdonik Dec 2009 A1
20100004633 Rothe et al. Jan 2010 A1
20100010476 Galdonik et al. Jan 2010 A1
20100063537 Ren et al. Mar 2010 A1
20100106182 Patel et al. Apr 2010 A1
20100191276 Lashinski Jun 2010 A1
20100179583 Carpenter et al. Jul 2010 A1
20100179584 Carpenter et al. Jul 2010 A1
20100179585 Carpenter et al. Jul 2010 A1
20100179647 Carpenter et al. Jul 2010 A1
20100185216 Garrison et al. Jul 2010 A1
20100185231 Lashinski Jul 2010 A1
20100211095 Carpenter Aug 2010 A1
20100228280 Groothius et al. Sep 2010 A1
20100312268 Belson Dec 2010 A1
20100324589 Carpenter et al. Dec 2010 A1
20110066221 White et al. Mar 2011 A1
20110144572 Kassab Jun 2011 A1
20120046739 Von Oepen et al. Feb 2012 A1
20120095500 Heuser Apr 2012 A1
20120172916 Fifer et al. Jul 2012 A1
20120203265 Heuser Aug 2012 A1
20130123835 Anderson et al. May 2013 A1
20130131714 Wang et al. May 2013 A1
20130231694 Lashinski Sep 2013 A1
20140052170 Heuser et al. Feb 2014 A1
20140094843 Heuser Apr 2014 A1
20140100597 Wang et al. Apr 2014 A1
20140243877 Lee et al. Aug 2014 A9
20140282379 Lee et al. Sep 2014 A1
20150039016 Naor et al. Feb 2015 A1
20150209131 Fifer et al. Jul 2015 A1
20150230910 Lashinski et al. Aug 2015 A1
20150335416 Fifer et al. Nov 2015 A1
20160058541 Schotzko et al. Mar 2016 A1
20160262864 Von Mangoldt et al. Sep 2016 A1
20160310255 Purcell et al. Oct 2016 A1
20170042658 Lee et al. Feb 2017 A1
20170112609 Purcell et al. Apr 2017 A1
20170181834 Fifer et al. Jun 2017 A1
20170202657 Lee et al. Jul 2017 A1
Foreign Referenced Citations (32)
Number Date Country
10049812 Apr 2002 DE
1400257 Mar 2004 EP
1253871 Feb 2007 EP
2303384 Apr 2011 EP
2391303 Dec 2011 EP
2480165 Aug 2012 EP
2658476 Nov 2013 EP
2387427 Aug 2014 EP
2003505216 Feb 2003 JP
2003526451 Sep 2003 JP
2003290231 Oct 2003 JP
3535098 Jun 2004 JP
2006500187 Jan 2006 JP
2008511401 Apr 2008 JP
2008515463 May 2008 JP
2011525405 Sep 2011 JP
9923976 May 1999 WO
0167989 Sep 2001 WO
2004026175 Apr 2004 WO
2005118050 Dec 2005 WO
2006026371 Mar 2006 WO
2008033845 Mar 2008 WO
2008100790 Aug 2008 WO
2008113857 Sep 2008 WO
2009032834 Mar 2009 WO
2010008451 Jan 2010 WO
2010081025 Jul 2010 WO
2010083527 Jul 2010 WO
2010088520 Aug 2010 WO
2011034718 Mar 2011 WO
2011017103 Oct 2011 WO
2012092377 Jul 2012 WO
Non-Patent Literature Citations (31)
Entry
Internet Archive Wayback Machine; Fiber Innovative Technology: FIT Capabilities; downloaded from http://web.archive.org/web/20010217040848/http://www.fitfibers.com/capabilities.htm (Archived Feb. 17, 2001; printed on Dec. 12, 2016).
Internet Archive Wayback Machine; Fiber Innovative Technology: 4DG Fibers; downloaded from http://web.archive.org/web/20011030070010/http://fitfibers.com/4DG_Fibers.htm (Archived Oct. 30, 2001; printed on Dec. 12, 2016).
Internet Archive Wayback Machine; Fiber Innovative Technology: FIT Products; downloaded from http://web.archive.org/web/20010408003529/http://www.fitfibers.com/product.htm (Archived Apr. 8, 2001; printed on Dec. 12, 2016).
Office Action for U.S. Appl. No. 15/080,345 dated Jan. 12, 2018, in 13 pages.
Final Office Action for U.S. Appl. No. 12/689,997 dated Nov. 5, 2012, in 11 pages.
Final Office Action for U.S. Appl. No. 12/871,708 dated May 28, 2014, in 31 pages.
Final Office Action for U.S. Appl. No. 13/497,235 dated Oct. 22, 2015, in 34 pages.
International Search Report in Application No. PCT/US2010/021417 dated Aug. 23, 2010, in 4 pages.
International Search Report in Application No. PCT/US2010/047166 dated Apr. 27, 2011, in 7 pages.
Notice of Allowance for U.S. Appl. No. 12/689,997 dated Jan. 9, 2013, in 9 pages.
Notice of Allowance for U.S. Appl. No. 12/871,708 dated Dec. 23, 2015, in 16 pages.
Notice of Allowance for U.S. Appl. No. 13/497,235 dated Jan. 6, 2017, in 16 pages.
Office Action for U.S. Appl. No. 12/689,997 dated Apr. 4, 2012 in 13 pages.
Office Action for U.S. Appl. No. 12/871,708 dated Oct. 11, 2013 in 34 pages.
Office Action for U.S. Appl. No. 12/871,708 dated Mar. 12, 2015, in 36 pages.
Office Action for U.S. Appl. No. 13/497,235 dated Jun. 15, 2016, in 25 pages.
Supplementary European Search Report in Application No. PCT/US2010/021417 dated Nov. 28, 2012, in 5 pages.
Final Office Action for U.S. Appl. No. 13/738,847 dated Sep. 11, 2015 in 12 pages.
Final Office Action for U.S. Appl. No. 13/738,847 dated Sep. 13, 2017 in 10 pages.
Office Action for U.S. Appl. No. 13/738,847 dated Apr. 29, 2015 in 16 pages.
Office Action for U.S. Appl. No. 13/738,847 dated May 20, 2016, in 9 pages.
Office Action for U.S. Appl. No. 13/738,847 dated Jan. 23. 2017, in 6 pages.
Office Action for U.S. Appl. No. 13/738,847 dated May 10, 2017 in 11 pages.
Office Action for U.S. Appl. No. 13,497,235 dated Apr. 2, 2015, in 21 pages.
International Search Report in Application No. PCT/US2010/043390 dated Apr. 8, 2011, in 11 pages.
International Search Report in Application No. PCT/US2011/067598 dated May 10, 2012, in 7 pages.
International Search Report in Application No. PCT/US2010/022590 dated Jan. 29, 2010, in 4 pages.
Search Opinion in European Application No. 09798236 dated Jul. 20, 2012, in 6 pages.
U.S. Appl. No. 16/934,962, filed Jul. 21, 2020, now U.S. Pat. No. 11,364,106.
U.S. Appl. No. 15/838,949, filed Dec. 12, 2017, now U.S. Pat. No. 10,743,977.
U.S. Appl. No. 13/738,847, filed Jan. 10, 2013.
Related Publications (1)
Number Date Country
20220280274 A1 Sep 2022 US
Provisional Applications (1)
Number Date Country
61145149 Jan 2009 US
Continuations (4)
Number Date Country
Parent 16934962 Jul 2020 US
Child 17752209 US
Parent 15838949 Dec 2017 US
Child 16934962 US
Parent 13738847 Jan 2013 US
Child 15838949 US
Parent 12689997 Jan 2010 US
Child 13738847 US